Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 09/07/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/07/22
ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 09/06/22
ROSEN, Leading Investor Counsel, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 09/03/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/02/22
CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the FirmNewsfile Corp • 09/01/22
ROSEN, Top Ranked Investor Counsel, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 09/01/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/31/22
INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on October 4, 2022 in Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.PRNewsWire • 08/29/22
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/28/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Class ActionNewsfile Corp • 08/26/22
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/25/22
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 08/24/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Securities Class Action FiledNewsfile Corp • 08/24/22
ROSEN, National Trial Lawyers, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/22/22
Kiromic Biopharma, Inc. Shareholder News: Robbins LLP is Investigating Kiromic Biopharma, Inc. (KRBP) on Behalf of ShareholdersBusiness Wire • 08/22/22
CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action LawsuitNewsfile Corp • 08/22/22
KRBP CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action LawsuitPRNewsWire • 08/20/22
ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/19/22
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. (KRBP) and Encourages Investors with Significant Losses to Contact the FirmBusiness Wire • 08/19/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Securities Class Action PendingNewsfile Corp • 08/19/22
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively ParticipateBusiness Wire • 08/18/22
KRBP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2022 in the Class Action Filed on Behalf of Kiromic BioPharma, Inc. Limited ShareholdersNewsfile Corp • 08/18/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Deadline Established in Securities Class ActionNewsfile Corp • 08/17/22
KRBP INVESTOR NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 08/15/22
